Stocks and InvestingStocks and Investing
Thu, September 16, 2021
Wed, September 15, 2021
Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021
Thu, September 9, 2021

Paul Matteis Downgraded (VRTX) to Hold and Decreased Target to $213 on, Sep 9th, 2021


Published on 2024-10-27 17:52:23 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Decreased Target from $244 to $213 on, Sep 9th, 2021.

Paul has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


These are the ratings of the 11 analyists that currently disagree with Paul


  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
  • Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Sunday, August 1st, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $248 on, Friday, July 30th, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $323 on, Friday, July 30th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Sell with Increased Target to $175 on, Friday, July 30th, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021